0.5523
price up icon5.28%   0.0277
after-market Dopo l'orario di chiusura: .56 0.0077 +1.39%
loading
Precedente Chiudi:
$0.5246
Aprire:
$0.547
Volume 24 ore:
2.69M
Relative Volume:
1.89
Capitalizzazione di mercato:
$50.01M
Reddito:
$153.73M
Utile/perdita netta:
$-106.79M
Rapporto P/E:
-0.3103
EPS:
-1.78
Flusso di cassa netto:
$-115.93M
1 W Prestazione:
-7.47%
1M Prestazione:
-27.98%
6M Prestazione:
-84.83%
1 anno Prestazione:
-84.79%
Intervallo 1D:
Value
$0.533
$0.5813
Intervallo di 1 settimana:
Value
$0.5231
$0.644
Portata 52W:
Value
$0.5231
$5.17

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
Nome
Sutro Biopharma Inc
Name
Telefono
650-392-8412
Name
Indirizzo
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
Dipendente
310
Name
Cinguettio
@SutroBio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
STRO's Discussions on Twitter

Confronta STRO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
STRO
Sutro Biopharma Inc
0.5523 50.01M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-17 Downgrade H.C. Wainwright Buy → Neutral
2025-03-14 Downgrade BofA Securities Buy → Underperform
2025-03-14 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 Downgrade Wedbush Outperform → Neutral
2024-05-08 Iniziato BofA Securities Buy
2023-11-09 Iniziato Deutsche Bank Buy
2023-10-06 Iniziato Oppenheimer Outperform
2023-03-21 Downgrade Wells Fargo Overweight → Equal Weight
2022-08-18 Ripresa Wells Fargo Overweight
2021-06-18 Iniziato H.C. Wainwright Buy
2020-12-03 Iniziato Stifel Buy
2020-09-02 Iniziato Jefferies Buy
2020-07-16 Iniziato Wells Fargo Overweight
2020-01-13 Iniziato SunTrust Buy
2019-10-07 Iniziato BTIG Research Buy
2019-07-18 Iniziato Deutsche Bank Buy
2019-04-29 Iniziato H.C. Wainwright Buy
2018-10-22 Iniziato JMP Securities Mkt Outperform
2018-10-22 Iniziato Piper Jaffray Overweight
2018-10-22 Iniziato Wedbush Outperform
Mostra tutto

Sutro Biopharma Inc Borsa (STRO) Ultime notizie

pulisher
Apr 18, 2025

Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st

Apr 18, 2025
pulisher
Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025
pulisher
Apr 16, 2025

Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada

Apr 16, 2025
pulisher
Apr 15, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Holdings Boosted by American Century Companies Inc. - Defense World

Apr 15, 2025
pulisher
Apr 15, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 15, 2025
pulisher
Apr 14, 2025

Sutro Biopharma announces board member departure By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Sutro Biopharma announces board member departure - Investing.com Australia

Apr 14, 2025
pulisher
Apr 12, 2025

Sei Investments Co. Takes Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 12, 2025
pulisher
Apr 07, 2025

Changing FacesPharma and Biotech HiresMarch 2025 - pharmaphorum

Apr 07, 2025
pulisher
Apr 07, 2025

Prudential Financial Inc. Increases Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 07, 2025
pulisher
Apr 05, 2025

Thrivent Financial for Lutherans Acquires Shares of 97,096 Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Apr 05, 2025
pulisher
Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges - Investing.com

Apr 03, 2025
pulisher
Apr 02, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Hold” from Analysts - Defense World

Apr 02, 2025
pulisher
Mar 25, 2025

Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Sells 110,734 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Mar 23, 2025
pulisher
Mar 20, 2025

Sutro Biopharma lays off dozens of employees in ‘strategic portfolio review’ - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

Biotech company based in Peninsula laying off 90% of staff - MSN

Mar 20, 2025
pulisher
Mar 20, 2025

HC Wainwright Expects Stronger Earnings for Sutro Biopharma - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle

Mar 19, 2025
pulisher
Mar 19, 2025

The Escalator: Stoke Therapeutics, Merck, Sutro Biopharma and more - Medical Marketing and Media

Mar 19, 2025
pulisher
Mar 18, 2025

Sutro Biopharma rises after market hours on portfolio review, restructuring - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

Sutro Biopharma’s (STRO) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

Sutro Biopharma stock rating downgraded at H.C. Wainwright - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Sutro Biopharma stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 17, 2025
pulisher
Mar 17, 2025

This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

HC Wainwright Downgrades Sutro Biopharma to Neutral From Buy, Price Target is $2 -March 17, 2025 at 08:33 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Oppenheimer Downgrades Sutro Biopharma to Market Perform From Outperform -March 17, 2025 at 07:57 am EDT - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Deutsche Bank Adjusts Sutro Biopharma Price Target to $5 From $10, Maintains Buy Rating - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma’s SWOT analysis: ADC developer’s stock faces pivotal shift By Investing.com - Investing.com South Africa

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma’s SWOT analysis: ADC developer’s stock faces pivotal shift - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma (NASDAQ:STRO) Cut to Market Perform at Citizens Jmp - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Array Technologies, Nextracker, Sutro Biopharma - TradingView

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma (STRO) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma (NASDAQ:STRO) Cut to Neutral at Wedbush - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Sutro Biopharma (NASDAQ:STRO) Cut to “Underperform” at Bank of America - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Sutro Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance UK

Mar 16, 2025

Sutro Biopharma Inc Azioni (STRO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Capitalizzazione:     |  Volume (24 ore):